I think it's a giant omission. As you know, there are many different vaccine technologies. You mentioned the adenovirus-based vaccines. There are two of those—AstraZeneca and Johnson & Johnson—and they're among the simplest to manufacture. We could manufacture them in Canada. It is a question of having a large vat in which you grow the cells that produce the vaccine. Then you purify the vaccine proteins, and then you formulate them and bottle them and all of that. We could do this in Canada. Contrary to the point of view that intellectual property is a big barrier here, AstraZeneca did license Brazil, Australia, India and several other countries to make its vaccine, and that has been done. Those countries are making the AstraZeneca vaccine. The intellectual property problems weren't that hard to solve. India is supplying it to its people as we speak. Brazil is rolling out the first doses this week. Australia, because it has so little COVID, is taking it more slowly.
This is something that Canada could do. The failure of the government to negotiate to produce the AstraZeneca vaccine back in the summer, as Brazil, India, Australia, Japan, Mexico and Argentina did, is a cardinal failure of this pandemic. Had we done so, we'd have something more right now.